Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Syndecan-3 as a Novel Biomarker in Alzheimer’s Disease

21 Mar 2022

Abstract excerpt

Early diagnosis of Alzheimer's disease (AD) is of paramount importance in preserving the patient's mental and physical health in a fairly manageable condition for a longer period. Reliable AD detection requires novel biomarkers indicating central nervous system (CNS) degeneration in the periphery. Members of the syndecan family of transmembrane proteoglycans are emerging new targets in inflammatory and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Glycation End Products research
Share to Alzheimer's disease research and treatments
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35328830
DOI: 10.3390/ijms23063407

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Syndecan-3 as a Novel Biomarker in Alzheimer’s DiseasePMID 35328830Read ↗

Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease ProgressionSemantic proximity Read ↗

CSF 14-3-3ζ is associated with tau pathology and elevated across the Alzheimer’s disease continuumSemantic proximity Read ↗

Syndecan-3 in Inflammation and AngiogenesisSemantic proximity Read ↗

Investigation of the ABI3 protein in microglia and its association with Alzheimer's disease in TgCRND8 mouse modelSemantic proximity Read ↗

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading PathologySemantic proximity Read ↗

Galectin-3, A Novel Endogenous Trem2 Ligand, Regulates Inflammatory Response and Aβ Fibrilation in Alzheimer’s DiseaseSemantic proximity Read ↗

Inflammatory markers of CHMP2B-mediated frontotemporal dementia.Semantic proximity Read ↗

Lymphocyte activation gene 3 (Lag3) expression is increased in prion infections but does not modify disease progressionSemantic proximity Read ↗

Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer’s disease in a mouse model of Aβ amyloidosisSemantic proximity Read ↗

Upregulation of Integrin beta-3 in astrocytes upon Alzheimer's disease progression in the 5xFAD mouse modelSemantic proximity Read ↗

CD33 in Alzheimer's disease.Semantic proximity Read ↗

Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.